ArticleResearch square2023

Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations.

Alison K Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.